Project Number 1R21AG068370-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for How does D2-CD33 reduce Alzheimer's disease risk? Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 17. Genetics i. Functional Validation of Genetic Risk and Protective Factors Researcher and Organization Principal Investigator ESTUS, STEVEN Principal Investigator First Name STEVEN Principal Investigator Last Name ESTUS Awardee Organization UNIVERSITY OF KENTUCKY Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-053: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) FY Overall Cost $420,750 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official OPANASHUK, LISA A
